Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03680846 · ClinicalTrials.gov registry record · NA
Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain
A NA study, sponsored by Nevro.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT03680846 is a NA study that has completed, run by Nevro. The registered enrollment target is 211 participants.
The verdict
NCT03680846, a NA study, has completed, sponsored by Nevro.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
This study is being conducted to document the safety, clinical effectiveness and cost-effectiveness of high-frequency SCS at 10 kHz (HF10™ Therapy) delivered through the Senza system in subjects with chronic refractory back pain (with or without leg pain) who are not considered candidates for spine surgery. This study is a multi-center, prospective, randomized study to compare the two treatment groups.
Interventions
- DEVICE HF10 Therapy
- OTHER CMM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2022-05-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03680846
The ClinicalTrials.gov registry entry for NCT03680846 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nevro, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HF10 Therapy is the first listed.
NCT03680846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03680846 about?
NCT03680846 is a clinical study titled "Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain". This study is being conducted to document the safety, clinical effectiveness and cost-effectiveness of high-frequency SCS at 10 kHz (HF10™ Therapy) delivered through the Senza system in subjects with chronic refractory back pain (with or without leg pain) who are not considered candidates for spine ...
What is the current status of trial NCT03680846?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2018-09-05. Estimated completion is 2022-05-09.
What interventions are being tested in trial NCT03680846?
The interventions under investigation include: HF10 Therapy (DEVICE), CMM (OTHER).
Who is sponsoring clinical trial NCT03680846?
This trial is sponsored by Nevro, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.